Your browser doesn't support javascript.
loading
Results of the compassionate program of inotuzumab ozogamicin for adult patients with relapsed or refractory acute lymphoblastic leukemia in Spain.
Torrent, Anna; Morgades, Mireia; García-Calduch, Olga; de Llano, María Paz Queipo; Montesinos, Pau; Navarro, Irene; Hernández-Rivas, Jesús María; Bárez-García, Abelardo; González-Campos, José; Oiartzabal, Itziar; Valero, Marta; Cervera, Marta; Zudaire, Teresa; Albors-Ferreiro, Manuel; López-Godino, Oriana; Gil-Cortés, Cristina; Villalón, Lucía; Saldaña, Raquel; Ribera, Josep-María.
Affiliation
  • Torrent A; Hematology Department, ICO-Hospital Germans Trias i Pujol, Josep Carreras Leukemia Research Institute (IJC), Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Morgades M; Hematology Department, ICO-Hospital Germans Trias i Pujol, Josep Carreras Leukemia Research Institute (IJC), Universitat Autònoma de Barcelona, Barcelona, Spain.
  • García-Calduch O; Hematology Department, ICO-Hospital Germans Trias i Pujol, Josep Carreras Leukemia Research Institute (IJC), Universitat Autònoma de Barcelona, Barcelona, Spain.
  • de Llano MPQ; Hematology Department, Hospital Universitario Virgen de la Victoria, Málaga, Spain.
  • Montesinos P; Hematology Department, Hospital Universitari i Politècnic La Fe, Valencia, Spain.
  • Navarro I; Hematology Department, Hospital Universitari i Politècnic La Fe, Valencia, Spain.
  • Hernández-Rivas JM; Departamento de Medicina, Universidad de Salamanca & Hematology Department, Hospital Universitario de Salamanca, Salamanca, Spain.
  • Bárez-García A; Department of Hematology, Hospital of Ávila, Ávila, Spain.
  • González-Campos J; Hematology Department, Hospital Universitario Virgen del Rocío, Sevilla, Spain.
  • Oiartzabal I; Servicio de Hematología y Hemoterapia, Hospital Universitario de Álava, Vitoria-Gasteiz, Álava, Spain.
  • Valero M; Hematology Department, Hospital Arnau de Vilanova, Valencia, Spain.
  • Cervera M; Hematology Department, Hospital Joan XXIII de Tarragona, Tarragona, Spain.
  • Zudaire T; Hematology Department, Hospital de Navarra, Navarra, Spain.
  • Albors-Ferreiro M; Hematology Department, Complexo Hospitalario Universitario, Ourense, Spain.
  • López-Godino O; Hematology Department, Hospital General Universitario Morales Meseguer, Murcia, Spain.
  • Gil-Cortés C; Hematology Department, Hospital General de Alicante, Alicante, Spain.
  • Villalón L; Hematology Department, Hospital Universitario Fundación Alcorcón, Madrid, Spain.
  • Saldaña R; Hematology Department, Hospital de Jerez, Jerez, Spain.
  • Ribera JM; Hematology Department, ICO-Hospital Germans Trias i Pujol, Josep Carreras Leukemia Research Institute (IJC), Universitat Autònoma de Barcelona, Barcelona, Spain.
Eur J Haematol ; 111(3): 485-490, 2023 Sep.
Article in En | MEDLINE | ID: mdl-37381686
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / Precursor Cell Lymphoblastic Leukemia-Lymphoma Type of study: Clinical_trials / Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Humans / Middle aged Country/Region as subject: Europa Language: En Journal: Eur J Haematol Journal subject: HEMATOLOGIA Year: 2023 Document type: Article Affiliation country: Spain
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / Precursor Cell Lymphoblastic Leukemia-Lymphoma Type of study: Clinical_trials / Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Humans / Middle aged Country/Region as subject: Europa Language: En Journal: Eur J Haematol Journal subject: HEMATOLOGIA Year: 2023 Document type: Article Affiliation country: Spain